Somin-On™ is a branded ashwagandha extract standardized to not less than 2% Sominone, a biologically active withanolide uniquely derived from Ashwagandha. Clinically studied in adults with mild cognitive impairment, it supports memory, attention, and information processing. Derived from Withania somnifera, Somin-On offers consistent potency for cognitive health and mental performance.
This Technical paper is brought to you by Arjuna Natural Pvt. Ltd


Brain & Mental Health
Food insecurity late in life linked to increased dementia risk, research suggests
Research conducted by the University of Michigan, US, has found that food insecurity during midlife and later in life is linked to increased risk of developing dementia by a fourfold, compared to individuals who remain food...

Brain & Mental Health
OmniActive’s root-only ashwagandha secures USP verification
OmniActive Health Technologies’ Zenroot has been approved by the US Pharmacopeia (USP) and is part of its Ingredient Verification Program for Dietary Ingredients, making it the first root-only ashwagandha to achieve this.

Brain & Mental Health
Glucose spotted as key driver of human brain evolution in study
Scientists have found evidence that fruit, honey, and other naturally sweet foods have helped fuel the evolution of the human brain, challenging the popular scientific standpoint of meat consumption being the main driver of human...
Related multimedia
Upcoming webinars

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot
Register now

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa
Register now

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement













